GoodRx Launches Erectile Dysfunction Subscription Service, Expands into New Market

GoodRx has launched a subscription service for erectile dysfunction treatment, including virtual consultations and FDA-approved medications for $18/month. Citi retains its Buy rating and $7 price target. The service is designed to rival Hims & Hers and potentially expand to other conditions like hair loss. GoodRx's website traffic reaches 350 million visits annually.

GoodRx Holdings Inc. (GDRX) has announced the launch of a new subscription service aimed at addressing erectile dysfunction (ED) treatment, marking a significant expansion into the healthcare sector. The service, designed to rival competitors like Hims & Hers, offers virtual consultations with licensed healthcare professionals, FDA-approved medications, and discreet home delivery for $18 per month.

The subscription service addresses common barriers to ED treatment, including high costs, long wait times, and social stigma. According to GoodRx, nearly 1 in 3 U.S. men report difficulty achieving or maintaining an erection without medication, yet fewer than 14% seek any form of treatment [1]. The new service aims to simplify access to necessary treatments, providing a stigma-free, convenient approach to ED care.

Key features of the GoodRx ED subscription service include:
- Virtual Consultations: Customers can chat directly with a healthcare professional online, often within the hour, with no in-person visit required.
- FDA-Approved Treatments: If clinically appropriate, customers receive a prescription for an FDA-approved medication.
- Discreet Delivery: Medication is delivered directly to the customer's door for no additional fee, in GoodRx's standard packaging.

Analysts have responded positively to the launch, with Citi retaining its Buy rating and $7 price target. The service has the potential to expand to other conditions such as hair loss, further diversifying GoodRx's offerings. GoodRx's website traffic reaches 350 million visits annually, indicating a strong foundation for growth in this new venture.

References:
[1] https://www.marketscreener.com/quote/stock/GOODRX-HOLDINGS-INC-112833794/news/GoodRx-Launches-New-Erectile-Dysfunction-Subscription-Service-to-Simplify-Access-and-Eliminate-Treat-50205090/
[2] https://www.gurufocus.com/news/2918846/goodrx-gdrx-shares-rise-with-launch-of-erectile-dysfunction-subscription-service
[3] https://hitconsultant.net/2025/06/10/goodrx-launches-subscription-service-for-erectile-dysfunction/
[4] https://www.gurufocus.com/news/2918573/goodrx-gdrx-introduces-subscription-service-for-ed-treatment-gdrx-stock-news